These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20346070)

  • 1. The International Normalized Ratio (INR) in the MELD score: problems and solutions.
    Porte RJ; Lisman T; Tripodi A; Caldwell SH; Trotter JF;
    Am J Transplant; 2010 Jun; 10(6):1349-53. PubMed ID: 20346070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory variability in assessment of the model of end-stage liver disease score.
    Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
    Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.
    Kamath PS; Kim WR
    Clin Liver Dis; 2009 Feb; 13(1):63-66. PubMed ID: 19150310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.
    Schouten JN; Francque S; Van Vlierberghe H; Colle I; Nevens F; Delwaide J; Adler M; Starkel P; Ysebaert D; Gadisseur A; De Winter B; Smits JM; Rahmel A; Michielsen P
    Clin Transplant; 2012; 26(1):E62-70. PubMed ID: 22032173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score.
    Tripodi A; Chantarangkul V; Primignani M; Dell'Era A; Clerici M; Iannuzzi F; Aghemo A; Cazzaniga M; Salerno F; Mannucci PM
    J Hepatol; 2009 Aug; 51(2):288-95. PubMed ID: 19501423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure.
    Arjal R; Trotter JF
    Clin Liver Dis; 2009 Feb; 13(1):67-71. PubMed ID: 19150311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.
    Magnusson M; Sten-Linder M; Bergquist A; Rajani R; Kechagias S; Fischler B; Németh A; Lindahl TL
    Thromb Res; 2013 Sep; 132(3):346-51. PubMed ID: 23993902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.
    Tripodi A; Chantarangkul V; Primignani M; Fabris F; Dell'Era A; Sei C; Mannucci PM
    Hepatology; 2007 Aug; 46(2):520-7. PubMed ID: 17659574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small difference in international normalized ratio may yield a significant impact on prioritizing patients listed for liver transplantation.
    Sarvary E; Seregely Z; Fazakas J; Kovacs F; Gaal I; Beko G; Varga J; Kobori L; Nemes B; Gorog D; Varga M; Langer RM; Monostory K; Jaray J; Gerlei Z
    Transplant Proc; 2010; 42(6):2317-22. PubMed ID: 20692471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
    Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
    Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.
    Al-Saeedi M; Yassein T; Schultze D; Nickkholgh A; Bruns H; Zorn M; Hinz U; Ganten TM; Schemmer P
    Ann Transplant; 2016 Nov; 21():675-682. PubMed ID: 27799654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory.
    Trotter JF; Olson J; Lefkowitz J; Smith AD; Arjal R; Kenison J
    Am J Transplant; 2007 Jun; 7(6):1624-8. PubMed ID: 17511686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective.
    Gatt A; Chen D; Pruthi RK; Kamath PS; Leise MD; Ashrani AA; Nichols WL; He R
    Semin Thromb Hemost; 2014 Nov; 40(8):845-51. PubMed ID: 25393635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyponatremia and mortality among patients on the liver-transplant waiting list.
    Kim WR; Biggins SW; Kremers WK; Wiesner RH; Kamath PS; Benson JT; Edwards E; Therneau TM
    N Engl J Med; 2008 Sep; 359(10):1018-26. PubMed ID: 18768945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
    Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
    Bellest L; Eschwège V; Poupon R; Chazouillères O; Robert A
    Hepatology; 2007 Aug; 46(2):528-34. PubMed ID: 17654598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J; Castro-Narro G; Navasa M
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
    Heuman DM; Mihas AA; Habib A; Gilles HS; Stravitz RT; Sanyal AJ; Fisher RA
    Liver Transpl; 2007 Jan; 13(1):30-7. PubMed ID: 17154400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.